Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits

DIABETES CARE

AMER DIABETES ASSOC

1. Arena
2. Merck
3. Metabolex
4. Novo Nordisk
5. Roche
6. Amgen
7. AstraZeneca
8. Eisai
9. Genzyme
10. National Cancer Institute
11. V Foundation for Cancer Research